Technological readiness and implementation of genomic-driven precision medicine for complex diseasesCenter for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Pfizer, Worldwide Research and Development, Stockholm, Sweden.
Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.
Department of Pediatrics, Linköpings Universitet, Linköping, Sweden; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology and Wallenberg Center for Molecular Medicine, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden; Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University and Sahlgrenska University Hospital, Gothenburg, Sweden, Sweden.
Department of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
Department of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Genetics and Bioinformatics, Oslo, Norway; Department of Obstetrics and Gynecology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Genetics and Genomics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Department of Radiation Sciences, Oncology, Umeå Universitet, Umeå, Sweden.
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, CBAR, University of Gothenburg, Gothenburg, Sweden; Department of Drug Treatment, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Rheumatology & Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Clinical Pharmacogenomics &Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Rheumatology & Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Institute for Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill NC, USA; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill NC, USA.
Show others and affiliations
2021 (English)In: Journal of Internal Medicine, ISSN 0954-6820, E-ISSN 1365-2796, Vol. 290, no 3, p. 602-620Article, review/survey (Refereed) Published
Abstract [en]
The fields of human genetics and genomics have generated considerable knowledge about the mechanistic basis of many diseases. Genomic approaches to diagnosis, prognostication, prevention and treatment - genomic-driven precision medicine (GDPM) - may help optimize medical practice. Here, we provide a comprehensive review of GDPM of complex diseases across major medical specialties. We focus on technological readiness: how rapidly a test can be implemented into health care. Although these areas of medicine are diverse, key similarities exist across almost all areas. Many medical areas have, within their standards of care, at least one GDPM test for a genetic variant of strong effect that aids the identification/diagnosis of a more homogeneous subset within a larger disease group or identifies a subset with different therapeutic requirements. However, for almost all complex diseases, the majority of patients do not carry established single-gene mutations with large effects. Thus, research is underway that seeks to determine the polygenic basis of many complex diseases. Nevertheless, most complex diseases are caused by the interplay of genetic, behavioural and environmental risk factors, which will likely necessitate models for prediction and diagnosis that incorporate genetic and non-genetic data.
Place, publisher, year, edition, pages
Blackwell Science Ltd. , 2021. Vol. 290, no 3, p. 602-620
Keywords [en]
complex disease, genomics, precision diagnostics, precision medicine, precision prevention, precision treatment
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
URN: urn:nbn:se:oru:diva-93115DOI: 10.1111/joim.13330ISI: 000669025500001PubMedID: 34213793Scopus ID: 2-s2.0-85109326832OAI: oai:DiVA.org:oru-93115DiVA, id: diva2:1580806
Funder
Swedish Research Council, D0886501 2018-02837 2014-03352 2009-1039 2018-03307Swedish Cancer SocietyKnut and Alice Wallenberg FoundationThe Karolinska Institutet's Research FoundationThe Cancer Research Funds of RadiumhemmetSwedish Heart Lung FoundationSwedish Foundation for Strategic Research, 15-0067Novo NordiskSwedish Rheumatism AssociationSwedish Society of Medicine
Note
Funding Agencies:
SciLifeLab
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Mental Health (NIMH)MH077139 MH1095320
European Commission 610307 733161 825843
European Research Council (ERC)
European Commission CoG-2015_681742_NASCENT
Strategic Research Area Epidemiology at Karolinska Institutet
Vth 80-year Foundation
Clinical Research Support (Avtal om Läkarutbildning och Forskning)
Swedish government
County councils
ALF-agreement
IMI2 Joint Undertaking 115974
European Federation of Pharmaceutical Industries and Associations with JDRF
H2020 Program ERA PerMed JTC 2018 Call (VR) 2018-05619
2021-07-162021-07-162023-06-02Bibliographically approved